Form CORRESP - Correspondence:
SEC Accession No. 0001437749-20-024927
Filing Date
2020-12-07
Accepted
2020-12-07 14:27:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 8078
2 atos20201207_correspimg001.jpg GRAPHIC 4733
  Complete submission text file 0001437749-20-024927.txt   15698
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations